MacroGenics, Inc., a clinical-stage biopharmaceutical company, discovers, develops, manufactures, and commercializes antibody-based therapeutics for the treatment of cancer in the United States. The company's product pipeline includes lorigerlimab, a bispecific DART molecule that targets checkpoint...
25 insider purchases on record · latest filing 2025-08-21.
Insiders have also filed 117 sale transactions at MGNX.